Fingerprint
Dive into the research topics of 'Initial testing (stage 1) of the polo-like kinase inhibitor volasertib (BI 6727), by the pediatric preclinical testing program'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Initial testing (stage 1) of the polo-like kinase inhibitor volasertib (BI 6727), by the pediatric preclinical testing program
Richard Gorlick, E. Anders Kolb, Stephen T. Keir, John M. Maris, C. Patrick Reynolds, Min H. Kang, Hernan Carol, Richard Lock, Catherine A. Billups, Raushan T. Kurmasheva, Peter J. Houghton, Malcolm A. Smith
Research output: Contribution to journal › Article › peer-review
47
Scopus
citations